Comprehensive Review: Repatha (Evolocumab) and Its Role in Managing Elevated Lipoprotein(a) 1. Introduction Repatha (evolocumab) is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). Approved by the FDA in 2015, Read more…
Prelungirea vieții prin eliminarea celulelor senescente IntroducereUna dintre cele mai promițătoare strategii pentru prelungirea duratei de viață și încetinirea îmbătrânirii constă în eliminarea celulelor senescente. Aceste celule nu se mai divid, dar continuă să secrete Read more…
Stem cell therapy offers a promising approach for treating inherited liver diseases by replacing or repairing damaged liver cells. Recent advancements in stem cell biology have enabled the development of innovative strategies to address these debilitating conditions. This article analyzes the potential of stem cell-based therapies to alleviate the burden of inherited liver diseases and explores the current state of research and clinical applications.